Lifestyle modification for patients with hypertension: alcohol restriction
Matayoshi, T.; Kawano, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 6): 236-241
2006
ISSN/ISBN: 0047-1852 PMID: 16981550 Document Number: 602335
Document emailed within 1 workday
Related Documents
Lai, J.; Hanton, P.; Jury, A.; Tuason, C. 2019: Reducing days of alcohol use improves lifestyle and wellbeing: an analysis of outcomes data from New Zealand adult community alcohol and other drug services New Zealand Medical Journal 132(1495): 54-64Mörlin, C.; Aberg, H. 1981: The effect of salt restriction and furosemide in patients investigated for renovascular hypertension Acta Chirurgica Scandinavica 147(3): 169-172
Karim, S.; Jafri, W.; Faryal, A.; Majid, S.; Salih, M.; Jafri, F.; Hamid, S.; Shah, H.A.; Nawaz, Z.; Tariq, U. 2011: Regular post dinner walk; can be a useful lifestyle modification for gastroesophageal reflux JPMA. Journal of the Pakistan Medical Association 61(6): 526-530
Grover, S.A.; Gray-Donald, K.; Joseph, L.; Abrahamowicz, M.; Coupal, L. 1994: Life expectancy following dietary modification or smoking cessation. Estimating the benefits of a prudent lifestyle Archives of Internal Medicine 154(15): 1697-1704
Bogdarina, I.G.; Zinkevich, V.E.; Bur'ianov, I.I.; Baev, A.A. 1985: Isolation of modification-restriction enzymes Hpai and HpaIi Biokhimiia 50(10): 1659-1664
Amitsur, M.; Morad, I.; Chapman-Shimshoni, D.; Kaufmann, G. 1992: HSD restriction-modification proteins partake in latent anticodon nuclease EMBO Journal 11(8): 3129-3134
Kartashova, I.M.; Nikol'skaia, I.I.; Debov, S.S. 1985: Separation of modification methylation and restriction enzymes from Shigella sonnei 47 Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 4: 31-35
Popovski, B. 1987: Localization of the genes coding for the specific modification-restriction system in the E. coli tF strain Veterinarno-Meditsinski Nauki 24(8): 9-12
Paniagua Repetto, H.; García Calatayud, S.; Castellano Barca, G.; Sarrallé Serrano, R.; Redondo Figuero, C. 2001: Tobacco, alcohol and illegal drug consumption among adolescents and the relationship with lifestyle and environment Anales Espanoles de Pediatria 55(2): 121-128
Korobeĭnikova, E.N.; Kudrevich, I.V.; Iashina, L.M. 2006: Oxidative modification of serum proteins in patients with ischemic heart disease and essential hypertension with or without dyslipoproteinemia Klinicheskaia Laboratornaia Diagnostika 4: 22-24
Matsumoto, M.; Kato, S.; Yokoyama, H.; Ishii, H. 1997: Effect of alcohol on patients with diabetes, hypertension or cardiovascular disease Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 597-603
Perkins, S. 2002: Lifestyle modifications and the management of hypertension Dentistry Today 21(3): 92-95
Chávez Rivera, I.; Fernández Barros, C.L. 1985: Alcohol and the cardiovascular system (II). Alcoholic cardiopathy and the possible relation of alcohol to atherosclerosis and arterial hypertension Archivos del Instituto de Cardiologia de Mexico 55(3): 269-287
Hoeger, K.; Davidson, K.; Kochman, L.; Cherry, T.; Kopin, L.; Guzick, D.S. 2008: The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials Journal of Clinical Endocrinology and Metabolism 93(11): 4299-4306
Beckenbauer, U.E.; Planz, G. 1984: Clonidine-diuretic combination in patients with essential hypertension. Modification of sympathetic activity and blood pressure as well as the reaction following sudden withdrawal Fortschritte der Medizin 102(31-32): 802-806
Adinegara, L.A.; Razzak, M.S. 2004: Does lifestyle increase the incidence of pregnancy-induced hypertension? Medical Journal of Malaysia 59(1): 39-44
Le Scanf, C.; Carcy, B.; Bonnefoy, S.; Fandeur, T.; Mercereau-Puijalon, O. 1997: A modification in restriction pattern of the Plasmodium falciparum Pf60 multigene family associated with a specific antigenic variation switch in the Palo Alto line Behring Institute Mitteilungen 1997(99): 16-24
O'Sullivan, D.J.; Klaenhammer, T.R. 1995: C.Llai is a bifunctional regulatory protein of the llai restriction modification operon from Lactococcus lactis Developments in Biological Standardization 85: 591-595
Neyses, L. 1992: Potassium restriction and essential hypertension Deutsche Medizinische Wochenschrift 117(35): 1341
Palmer, R.A. 1980: Sodium restriction for treatment of hypertension Canadian Medical Association Journal 122(10): 1130-1131